What is the Rokit Healthcare Inc. stock price forecast?

Rokit Healthcare Inc. is currently trading at ₩76,500. View real-time AI analysis on Alpha Lenz.

What is Rokit Healthcare Inc. insider trading activity?

View the latest insider trading data for Rokit Healthcare Inc. on Alpha Lenz.

What is Rokit Healthcare Inc.'s P/E ratio?

Rokit Healthcare Inc.'s P/E ratio is -78.2.

Rokit Healthcare Inc.

KRX · 376900

₩76,500

Ask about Rokit Healthcare Inc.'s future dividend policy...

Alpha Chat Insight

“Rokit Healthcare Inc. trades at a P/E of -78.2 (undervalued) with solid ROE of 9.9%.”

Ask for details →

Company Overview

Rokit Healthcare Inc. is a biotechnology company specializing in hyper-personalized organ regenerative healthcare solutions. Founded in 2012 and headquartered in Seoul, South Korea, the company is recognized for its pioneering work in medical 3D bioprinting, offering advanced bioprinters and disposable medical device kits designed for regenerative therapies. Rokit Healthcare’s portfolio includes solutions for skin regeneration—such as therapies for diabetic foot ulcers—cartilage regeneration for osteoarthritis, and kidney regeneration for chronic kidney disease. Additional offerings encompass bioinks, human adult stem cell culture media, reconstructed human epidermis models, and anti-aging supplements. Positioned within the biotechnology and medical research sector, Rokit Healthcare plays a significant role in advancing regenerative medicine, aiming to transform treatment paradigms for chronic and degenerative diseases through personalized and autologous therapies.

CEO유석환

Websitehttps://rokithealthcare.com

SectorHealthcare

IndustryMedical Care Facilities

Employees72

Company Statistics

FY 2024

Profile

₩1,214,344,858,500Market Cap

₩13,111,237,720Revenue

15.87MShares Out

72Employees

Margins

45.63%Gross

-31.68%EBITDA

-42.50%Operating

-55.96%Pre-Tax

-58.65%Net

Valuation

-78.22P/E

-7.76P/B

45.61EV/Sales

-146.80EV/EBITDA

-115.05P/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-67.88%ROA

9.92%ROE

-4.34%ROIC

Financial Health

₩3,009,292,850Cash & Cash Equivalents

₩85,438,265,950Net Debt

-114.69%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Rokit Healthcare Inc. trades at a P/E of -78.2 (undervalued) with solid ROE of 9.9%.”

Ask for details →

Frequently Asked Questions

Rokit Healthcare Inc. (ticker: 376900) is a company listed on KRX in the Healthcare sector (Medical Care Facilities). It has approximately 72 employees. Market cap is $1.2T.

The current price is ₩76,500 with a P/E ratio of -78.22x and P/B of -7.76x.

ROE is 9.92% and operating margin is -42.50%. Annual revenue is $13.1B.